[Cutaneous necrosis in patient with chronic hepatitis].
García-Morán
S
S
Servicio de Aparato Digestivo, Hospital General Yagüe, Burgos, Spain.
Sáez-Royuela
F
F
Muñoz Fernández-Lomana
C
C
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000009:adverse effects; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009336:Necrosis; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012867:Skin / Q000473:pathology*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin